Cefamandole nafate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefamandole nafate and what is the scope of freedom to operate?

Cefamandole nafate is the generic ingredient in one branded drug marketed by Lilly and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for cefamandole nafate

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	2
Drug Master File Entries:	3
Raw Ingredient (Bulk) Api Vendors:	83
DailyMed Link:	cefamandole nafate at DailyMed

Medical Subject Heading (MeSH) Categories for cefamandole nafate

Anti-Bacterial Agents

Anatomical Therapeutic Chemical (ATC) Classes for cefamandole nafate

J01DC	Second-generation cephalosporins
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for cefamandole nafate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	MANDOL	cefamandole nafate	INJECTABLE;INJECTION	062560-001	Sep 10, 1985		DISCN	No	No
Lilly	MANDOL	cefamandole nafate	INJECTABLE;INJECTION	050504-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	MANDOL	cefamandole nafate	INJECTABLE;INJECTION	062560-002	Sep 10, 1985		DISCN	No	No
Lilly	MANDOL	cefamandole nafate	INJECTABLE;INJECTION	050504-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	MANDOL	cefamandole nafate	INJECTABLE;INJECTION	050504-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	MANDOL	cefamandole nafate	INJECTABLE;INJECTION	050504-004	Approved Prior to Jan 1, 1982		DISCN	No	No